Regulatory History
YEAR
REGULATORY
|
2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
DCGI
![]() |
1 | 1 | 1 | 1 | 2 | 1 | 2 | 2 | 3 | 2 | 1 | |||||||||
USFDA
![]() |
1 | 1 | 1 | 1 | 4 | 5 | 3 | 3 | 1 | 3 | 5 | 2 | 3 | 2 | 1 | 1 | 4 | 1 | ||
ANVISA
![]() |
1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 1 | 1 | |||||||||
WHO
![]() |
3 | 5 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||||
EMA
![]() |
1 | 1 | 2 | 1 | 1 | 2 | 2 | |||||||||||||
MCC - South Africa
![]() |
1 | 1 | ||||||||||||||||||
NPRA - Malaysia
![]() |
1 | 2 | ||||||||||||||||||
MoH - Thailand
![]() |
1 | |||||||||||||||||||
MoH - Turkey
![]() |
1 |
BA/BE Regulatory Approvals by Location
All our locations adhere to global regulatory standards
Ahmedabad

- DCGI
- US FDA
- WHO
- EMA
- ANVISA
Mumbai

- DCGI
- US FDA
- WHO
- EMA
- ANVISA
- NPRA-Malaysia
Vadodara

- DCGI
- US FDA
- WHO

Dr. Santosh Joshi
CEO
"Our company's regulatory department is the backbone of our operations. With unrivaled expertise, they navigate the ever-evolving landscape of compliance, ensuring our services adhere to all industry regulations. Their dedication enables us to deliver cutting-edge solutions with the highest standards of quality and safety, setting us apart as a trusted partner."
Clinical Data Services site approvals
Sr. No | Regulatory Agency | Location | Therapeutic area | Inspection Timing |
---|---|---|---|---|
1 | USFDA | Ahmedabad | Psychiatry | July 2012 |
2 | USFDA | Ahmedabad | Psychiatry | July 2012 |
3 | USFDA | Surat | Psychiatry | Sep 2015 |
4 | USFDA | Junagadh | Psychiatry | Apr 2015 |
5 | USFDA | Ahmedabad | Psychiatry | Jun 2018 |
6 | USFDA | Vijayawada | Oncology | Oct 2018 |
7 | USFDA | Surat | Oncology | Dec 2018 |
8 | USFDA | Vadodara | Oncology | Jan 2019 |
9 | USFDA | Bengaluru | Oncology | Jan 2020 |
10 | USFDA | Tamil Nadu | Oncology | Feb 2020 |
11 | NPRA | Junagadh | Psychiatry | Mar 2023* |
Biologics Regulatory Approvals
Our biologics facility has been granted DCGI approval with a validity period from September 2021 to September 2026.
Rest assured that we are fully committed to maintaining our high standards, and our facility is fully GCLP/GLP compliant.
Read more